NCT01998139View on ClinicalTrials.gov

Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis

CompletedOBSERVATIONAL
Enrollment

137

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Systemic Inflammatory Response Syndrome
Trial Locations (2)

10021

Weill Cornell Medical College, New York

Unknown

Hamad Medical Corporation, Doha

Sponsors

Collaborators (1)

Hamad Medical Corporation
All Listed Sponsors
collaborator

Hamad Medical Corporation

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER

NCT01998139 - Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis | Biotech Hunter | Biotech Hunter